Clearmind Medicine (CMND) Profit After Tax (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Profit After Tax of $2.0 million for Q2 2026, up 161.2% year-over-year from $783928.0 in Q2 2025, and down 46.88% quarter-over-quarter from $3.9 million in Q1 2026.
Clearmind Medicine (CMND) Profit After Tax (2022 - 2026) Analysis & Trends
Clearmind Medicine's Profit After Tax history runs 5 years deep, the most recent figure standing at $2.0 million for Q2 2026.
- In Q2 2026, Profit After Tax rose 161.2% year-over-year to $2.0 million; the TTM figure through Apr 2026 stood at $6.3 million (up 211.38% YoY), while the FY2025 annual figure was -$3.9 million, up 25.26% from the prior year.
- Profit After Tax for Q2 2026 stood at $2.0 million, down from $3.9 million in the prior quarter.
- The five-year high for Profit After Tax was $3.9 million in Q1 2026, with the low at -$13.2 million in Q4 2023.
- The 5-year median for Profit After Tax is $846072.5 (2024), against an average of -$709854.5.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax tumbled 741.49% in 2023, then jumped 264.04% in 2024.
- Clearmind Medicine's Profit After Tax stood at -$1.6 million in 2022, then sank by 741.49% to -$13.2 million in 2023, then advanced by 26.93% to -$9.6 million in 2024, then soared by 90.7% to -$894789.0 in 2025, then surged by 328.84% to $2.0 million in 2026.
- Business Quant data shows CMND's Profit After Tax at $2.0 million in Q2 2026, $3.9 million in Q1 2026, and -$894789.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.05 Mn |
| Jan 31, 2026 | 3.85 Mn |
| Oct 31, 2025 | -894,789.00 |
| Jul 31, 2025 | 1.31 Mn |
| Apr 30, 2025 | 783,928.00 |
| Jan 31, 2025 | 1.07 Mn |
| Oct 31, 2024 | -9.62 Mn |
| Jul 31, 2024 | 2.09 Mn |
| Apr 30, 2024 | 908,217.00 |
| Jan 31, 2024 | 1.37 Mn |
| Oct 31, 2023 | -13.17 Mn |
| Jul 31, 2023 | 575,187.00 |
| Apr 30, 2023 | 1.53 Mn |
| Jan 31, 2023 | 1.90 Mn |
| Oct 31, 2022 | -1.57 Mn |
| Jul 31, 2022 | -1.48 Mn |
| Apr 30, 2022 | -1.84 Mn |
| Jan 31, 2022 | -1.65 Mn |